Alpha-1 Anti-trypsin Deficiency
·MeSH: alpha 1-Antitrypsin Deficiency
Prevalence
30.0 / 100K
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Alpha-1 Anti-trypsin Deficiency?
BioSniper tracks 2 drugs in development for Alpha-1 Anti-trypsin Deficiency across 1 company.
How many clinical trials target Alpha-1 Anti-trypsin Deficiency?
There are 1 clinical trial targeting Alpha-1 Anti-trypsin Deficiency tracked by BioSniper.
What is the prevalence of Alpha-1 Anti-trypsin Deficiency?
The estimated prevalence of Alpha-1 Anti-trypsin Deficiency is approximately 30.0 per 100,000 population.
Deep-dive into Alpha-1 Anti-trypsin Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis